| Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma (NCT05316467) | Xiaojun Chen | 2022-05-01 |
| The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma (NCT03877627) | Second Affiliated Hospital of Wenzhou Medical University | 2022-04-01 |
| Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO (NCT05078047) | UNICANCER | 2022-03-08 |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma (NCT05121363) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-12-01 |
| Targeting Inflammation for Endometrial Cancer Prevention (NCT05407025) | Mayo Clinic | 2021-12-01 |
| Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer (NCT04576104) | Northwestern University | 2021-11-29 |
| Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer (NCT05139368) | University of Utah | 2021-11-11 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma (NCT05036681) | M.D. Anderson Cancer Center | 2021-09-30 |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia (NCT04839614) | Dana-Farber Cancer Institute | 2021-08-01 |
| Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma (NCT04716686) | Shandong University | 2021-06-01 |
| Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy) (NCT06790004) | Azienda USL Reggio Emilia - IRCCS | 2021-05-10 |
| Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy (NCT04713618) | Ohio State University Comprehensive Cancer Center | 2021-01-30 |
| GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab (NCT04652076) | NETRIS Pharma | 2020-12-14 |
| Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer (NCT04567771) | Mayo Clinic | 2020-12-04 |
| A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer (NCT04159155) | University Health Network, Toronto | 2020-11-17 |
| A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma (NCT04251416) | Yale University | 2020-03-17 |
| Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) (NCT04152499) | Klus Pharma Inc. | 2020-02-28 |
| A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment (NCT04178460) | Zai Lab (Shanghai) Co., Ltd. | 2020-02-03 |
| Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates (NCT04474184) | Mayo Clinic | 2020-02-01 |
| Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors (NCT04634617) | M.D. Anderson Cancer Center | 2020-01-09 |
| The Application of Real-Time Near-infrared Imaging in Gynecological Surgery (NCT04224467) | Chen Chunlin | 2020-01-01 |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma (NCT04080284) | Northwell Health | 2019-12-30 |
| Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives (NCT04257045) | M.D. Anderson Cancer Center | 2019-08-21 |
| Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma (NCT03945786) | Xuanwu Hospital, Beijing | 2019-06-03 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer (NCT04678414) | M.D. Anderson Cancer Center | 2019-04-01 |
| UTOLA: UTerin OLAparib (NCT03745950) | ARCAGY/ GINECO GROUP | 2019-02-01 |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy (NCT03671811) | City of Hope Medical Center | 2019-01-21 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors (NCT03372720) | Ohio State University Comprehensive Cancer Center | 2018-05-11 |
| Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care (NCT03460483) | Ohio State University Comprehensive Cancer Center | 2018-03-30 |
| Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors (NCT03367923) | Stanford University | 2017-12-01 |
| Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer (NCT03300557) | National Cancer Institute (NCI) | 2017-11-15 |
| A Study of Nivolumab in Selected Uterine Cancer Patients (NCT03241745) | Memorial Sloan Kettering Cancer Center | 2017-08-03 |
| A Study Evaluating MM-310 in Patients With Solid Tumors (NCT03076372) | Merrimack Pharmaceuticals | 2017-02-22 |
| First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors (NCT02977195) | Centre Leon Berard | 2017-01-09 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer (NCT02983279) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-09-20 |
| Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer (NCT03902379) | Rutgers, The State University of New Jersey | 2016-07-27 |
| Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies (NCT02807844) | Novartis Pharmaceuticals | 2016-06-29 |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024) | PharmaMar | 2016-05-06 |
| Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) (NCT02730923) | Centre Leon Berard | 2016-04-01 |
| MK-3475 Immunotherapy in Endometrial Carcinoma (NCT02630823) | Washington University School of Medicine | 2016-02-05 |
| Preoperative Olaparib Endometrial Carcinoma Study (POLEN) (NCT02506816) | MedSIR | 2016-02-01 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) (NCT02584478) | Advenchen Laboratories, LLC | 2015-12-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Improved Method of Detecting Cancer Metastases (NCT02368067) | Southeastern Regional Medical Center | 2014-06-01 |
| Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies (NCT02025985) | Karyopharm Therapeutics Inc | 2014-04-09 |
| Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma (NCT02017353) | University Hospital, Gasthuisberg | 2013-10-01 |
| Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors (NCT02465541) | Ohio State University Comprehensive Cancer Center | 2013-07-23 |
| Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology (NCT04830332) | Erdemli State Hospital | 2011-12-01 |
| A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma (NCT01455493) | Genentech, Inc. | 2011-12-01 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |
| Trisenox® in Women With Metastatic Endometrial Cancer (NCT01184053) | UNC Lineberger Comprehensive Cancer Center | 2010-03-01 |
| Letrozole as a Treatment of Endometrial Cancer (NCT00997373) | University of California, Davis | 2009-10-01 |
| Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors (NCT00756847) | Sanofi | 2008-09-01 |
| Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (NCT00729586) | National Cancer Institute (NCI) | 2008-09-01 |
| Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer (NCT00791635) | M.D. Anderson Cancer Center | 2008-07-11 |
| Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer (NCT00879359) | The Cleveland Clinic | 2007-12-01 |
| Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate (NCT00483327) | NYU Langone Health | 2007-06-01 |
| Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia (NCT01273636) | National Taiwan University Hospital | 2005-01-01 |
| Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. (NCT00334295) | AstraZeneca | 2002-12-01 |